Publikationen

Wichtiger Hinweis

Diese Seite wird aktuell überarbeitet.

Bei Fragen zu der Internetseite erreichen Sie die Onlineredaktion des Universitätsklinikums Augsburg unter folgender E-Mail-Adresse: online@uk-augsburg.de.

Vielen Dank!

Veröffentlichungen zum Thema

Studienliteratur Rhabdoidtumoren 

1. Warmuth-Metz M, Bison B, Gerber NU, Pietsch T, Hasselblatt M, Frühwald MC: Bone Involvement in Atypical Teratoid/Rhabdoid Tumors of the CNS. AJNR. American journal of neuroradiology 2013, Epub ahead of print [PMID: 23681355] 

2. Kerl K, Holsten T, Frühwald MC: Rhabdoid Tumors: Clinical Approaches and Molecular Targets for Innovative Therapy. Pediatric hematology and oncology 2013, epub ahead of print [PMID: 23848359] 

3. von Hoff K, Hinkes B, Dannenmann-Stern E, von Bueren AO, Warmuth-Metz M, Soerensen N, Emser A, Zwiener I, Schlegel PG, Kuehl J, Frühwald MC, Kortmann RD, Pietsch T, Rutkowski S: Frequency, risk-factors and survival of children with atypical teratoid rhabdoid tumors (AT/RT) of the CNS diagnosed between 1988 and 2004, and registered to the German HIT database. Pediatric blood & cancer 2011, 1; 57: 978 [PMID: 21796761] 

4. Hasselblatt M, Gesk S, Oyen F, Rossi S, Viscardi E, Giangaspero F, Giannini C, Judkins AR, Frühwald MC, Obser T, Schneppenheim R, Siebert R, Paulus W: Nonsense mutation and inactivation of SMARCA4 (BRG1) in an atypical teratoid/rhabdoid tumor showing retained SMARCB1 (INI1) expression. The American journal of surgical pathology 2011, 35: 933 [PMID: 21566516] 

5. Schneppenheim R, Frühwald MC, Gesk S, Hasselblatt M, Jeibmann A, Kordes U, Kreuz M, Leuschner I, Martin Subero JI, Obser T, Oyen F, Vater I, Siebert R: Germline nonsense mutation and somatic inactivation of SMARCA4/BRG1 in a family with rhabdoid tumor predisposition syndrome. American journal of human genetics 2010, 86: 279 [PMID: 20137775] 

6. van den Heuvel-Eibrink MM, van Tinteren H, Rehorst H, Coulombe A, Patte C, de Camargo B, de Kraker J, Leuschner I, Lugtenberg R, Pritchard-Jones K, Sandstedt B, Spreafico F, Graf N, Vujanic GM: Malignant rhabdoid tumours of the kidney (MRTKs), registered on recent SIOP protocols from 1993 to 2005: A report of the SIOP renal tumour study group. Pediatr Blood Cancer 2010 [Epub ahead of print] [PMID: 21182029] 

7. Lünenbürger H, Lanvers-Kaminsky C, Lechtape B, Frühwald MC: Systematic analysis of the antiproliferative effects of novel and standard anticancer agents in rhabdoid tumor cell lines. Anti-cancer drugs 2010, 21: 514 [PMID: 20147838] 

8. Frühwald MC, Krefeld B, Benesch M, Büchner J, Boos J, Ebetsberger G, Graf N, Kortmann R, Nysom K, Rutkowski S, Schneppenheim R, Siebert R, Timmermann B, Warmuth-Matz M, Hasselblatt M: The European Rhabdoid Registry (EU-RHAB) – A comprehensive approach towards biology and clinical management. Neurooncology 2010, 12:ii36 [DOI: 10.1093/neuonc/noq043] 

9. Reinhard H, Reinert J, Beier R, Furtwängler R, Alkasser M, Rutkowski S, Frühwald M, Koscielniak E, Leuschner I, Kaatsch P, Graf N: Rhabdoid tumors in children: prognostic factors in 70 patients diagnosed in Germany. Oncology reports 2008, 19: 819 [PMID: 18288421] 

INFORMATIONS FOR PARENTS